Search

everythinglearnresearchcommunity

for

Search:↓

Cyclosporin A and FK506 can start new hair growth without needing immunosuppression.

PDGF signaling may play a role in hair growth cycle regulation.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Ritlecitinib is an effective new treatment for Alopecia Areata.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

AD198 is more effective than doxorubicin in stopping certain dog cancer cells.

Tridax procumbens significantly lowers blood sugar in diabetic rats.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

TGF-β1 from dermal papilla cells suppresses hair growth, and targeting it may help treat androgenetic alopecia.

New pregnane derivatives were more effective than finasteride at inhibiting a key enzyme for male pattern baldness.

Sinapic acid may help fight obesity and promote hair growth.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

Thymosin beta 4 protects cells from damage by blocking a harmful microRNA and boosting a protective gene.

Tianeptine may help prevent hair loss by promoting hair growth and reducing cell death.

The more lipophilic the progesterone derivative, the better it binds to androgen receptors and has antiandrogenic effects.

The medicine Diane is effective in treating hair loss, severe acne, and excessive hair growth.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

A peptide from hair follicle stem cells can boost hair growth.

Stopping gefitinib improved scalp condition in a woman with lung cancer.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

Paeonol-loaded gels may help reduce inflammation and skin damage in atopic dermatitis.

Nifedipine may help treat perniosis, improving symptoms and clearing lesions for some patients.

Ritlecitinib is effective long-term for treating alopecia areata in teens.

Certain derivatives are more effective 5α-reductase type 2 inhibitors than finasteride.

A patient developed nerve problems as a side effect of a hair loss treatment called tofacitinib.

New treatment with green tea polyphenols and nicotinamide improves skin problems from cancer therapy.

Prostaglandin helps regenerate hair follicles after radiation damage.

A new therapy for a skin blistering condition has not been developed yet.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.